Parkinson, R J <br/><br/>
A vaccination strategy for the long-term suppression of androgens in advanced prostate cancer.  [electronic resource] 

 -  European urology  Feb 2004 
 - 171-4; discussion 174-5 p.  digital 
<br/><br/> Publication Type: Clinical Trial; Clinical Trial, Phase I; Clinical Trial, Phase II; Controlled Clinical Trial; Journal Article 
<br/><br/><label>ISSN: </label>0302-2838 
<br/><br/><label>Standard No.: </label>10.1016/j.eururo.2003.10.007  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Androgen Antagonists--therapeutic use<br/>Cancer Vaccines--administration & dosage<br/>Diphtheria Toxoid--chemistry<br/>Disease Progression<br/>Dose-Response Relationship, Drug<br/>Gonadotropin-Releasing Hormone--chemistry<br/>Humans<br/>Male<br/>Oligopeptides--chemistry<br/>Prostate-Specific Antigen--blood<br/>Prostatic Neoplasms--blood<br/>Testosterone--blood